Abstract:Objective::A series of experiments were carried out to study the comparative decorporation efficacy and toxicity of three tetradentate hydroxypyridinone ligands (3LI-1-Cm-3,2-HOPO, 5LIO-1-Cm-3,2-HOPO, and 7LIO-1-Cm-3,2-HOPO) with the variation of the linker length and the substituents.Methods::Three ligands were obtained from a 4-step synthesis via the amidation of HOPO unit and different backbones. Potentiometric titrations were carried out to evaluate the formation constants of their corresponding uranyl complexes. CCK-8 and colony formation assays were used to compare the cytotoxicity of the three ligands and uranyl using renal proximal tubular epithelial (NRK-52E) cells. In vitro uranium removal assays were performed to assess decorporation efficiencies of those ligands by co-incubating uranium and chelators with NRK-52E cells for 48 h.Results::Among the three ligands, 5LIO-1-Cm-3,2-HOPO exhibits the highest uranyl affinity (log β110 = 18.6(7)) in comparison to the other two ligands (log β110 = 14.9(2) for 3LI-1-Cm-3,2-HOPO and log β110 = 16.7(1) for 7LIO-1-Cm-3,2-HOPO). The results of CCK-8 tests and colony formation assays further elucidate that 5LIO-1-Cm-3,2-HOPO and 7LIO-1-Cm-3,2-HOPO both show a similar level of cytotoxicity compared with ZnNa 3-DTPA at relatively low ligand concentrations. In contrast, in the 3LI-1-Cm-3,2-HOPO treated group, the cell viability decreased markedly with the increase of the ligand concentrations, and the colony formation capability of NRK-52E cells was inhibited. Furthermore, the comparative decorporation efficacy of the three ligands was obtained from in vitro uranium removal assays, suggesting that these ligands could significantly inhibit the cellular uptake and prompt the cellular release of uranium from NRK-52E cells by the level of 81.9%, 91.8%, and 87.1%, respectively. Conclusion::Our current results demonstrate that the linker/backbone species would significantly affect the decorporation efficacy and toxicity of the tetradentate 3-hydroxy-2-pyridinone ligands, which is informative for the future design and modification of novel decorporation ligands.

In Vivo Uranium Decorporation by a Tailor-Made Hexadentate Ligand

A 3,2-Hydroxypyridinone-based Decorporation Agent That Removes Uranium from Bones in Vivo

Structural And Thermodynamics Studies On Polyaminophosphonate Ligands For Uranyl Decorporation

A Protein Engineered to Bind Uranyl Selectively and with Femtomolar Affinity

Amidoxime-Functionalized Covalent Organic Nanosheets for Sequestration of Uranium in Vivo.

3-Hydroxy-2-pyrrolidinone As a Potential Bidentate Ligand for in Vivo Chelation of Uranyl with Low Cytotoxicity and Moderate Decorporation Efficacy: A Solution Thermodynamics, Structural Chemistry, and in Vivo Uranyl Removal Survey.

Theoretical Prediction of Electronically Modulated Pentadentate Ligands for Extraction Uranium from Seawater

In Vivo Uranium Antidotal Therapy by a Nanoscale Metal-Organic Framework.

Efficient Removal of Uranium from the Kidneys by a Picolinate-Based Pentadentate Chelator

Perilla frutescens: A new strategy for uranium decorporation

Improving <i>in vivo</i> Uranyl Removal Efficacy of a Nano-Metal Organic Framework by Interior Functionalization with 3-Hydroxy-2-pyridinone

Design, Synthesis, and Characterization of a Bifunctional Chelator with Ultrahigh Capacity for Uranium Uptake from Seawater Simulant

In Vivo Uranium Sequestration Using a Nanoscale Metal–Organic Framework

Theoretical Insights into Selective Extraction of Uranium from Seawater with Tetradentate N,O-mixed Donor Ligands

Hinokitiol, an Advanced Bidentate Ligand for Uranyl Decorporation

Study of the Decorporation Efficacy and Toxicity of Tetradentate 3-Hydroxy-2-pyridinone Ligands at the Cellular Level

Hexadentate Β-Dicarbonyl(bis-catecholamine) Ligands for Efficient Uranyl Cation Decorporation: Thermodynamic and Antioxidant Activity Studies.

Synthesis of bifunctional biscatecholamine chelators for uranium decorporation

Skeleton Engineering of Homocoupled Conjugated Microporous Polymers for Highly Efficient Uranium Capture Via Synergistic Coordination.

Amidoxime functionalized chitosan for uranium sequestration in vivo

Ssdna Functionalized Nanodiamonds for Uranium Decorporation